LGND - Ligand Pharmaceuticals Incorporated

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.22B
Enterprise Value 31.35B
Trailing P/E 3.44
Forward P/E 129.22
PEG Ratio (5 yr expected) 11.08
Price/Sales (ttm)9.31
Price/Book (mrq)2.06
Enterprise Value/Revenue 35.65
Enterprise Value/EBITDA 68.59

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 320.12%
Operating Margin (ttm)58.81%

Management Effectiveness

Return on Assets (ttm)6.58%
Return on Equity (ttm)96.93%

Income Statement

Revenue (ttm)238.78M
Revenue Per Share (ttm)11.39
Quarterly Revenue Growth (yoy)-22.60%
Gross Profit (ttm)217.25M
EBITDA 157.23M
Net Income Avi to Common (ttm)764.38M
Diluted EPS (ttm)32.97
Quarterly Earnings Growth (yoy)1,371.60%

Balance Sheet

Total Cash (mrq)1.5B
Total Cash Per Share (mrq)76.61
Total Debt (mrq)649.25M
Total Debt/Equity (mrq)60.12
Current Ratio (mrq)8.39
Book Value Per Share (mrq)54.92

Cash Flow Statement

Operating Cash Flow (ttm)178.56M
Levered Free Cash Flow (ttm)1.07B

Trading Information

Stock Price History

Beta (3Y Monthly) 1.73
52-Week Change 3-39.93%
S&P500 52-Week Change 34.92%
52 Week High 3278.62
52 Week Low 398.56
50-Day Moving Average 3121.35
200-Day Moving Average 3128.85

Share Statistics

Avg Vol (3 month) 3461.42k
Avg Vol (10 day) 3224.49k
Shares Outstanding 519.6M
Float 17.57M
% Held by Insiders 13.44%
% Held by Institutions 1130.68%
Shares Short (Apr 30, 2019) 46.78M
Short Ratio (Apr 30, 2019) 421.68
Short % of Float (Apr 30, 2019) 441.74%
Short % of Shares Outstanding (Apr 30, 2019) 434.47%
Shares Short (prior month Mar 29, 2019) 47.05M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 2, 2010
Last Split Factor (new per old) 26/1
Last Split Date 3Nov 19, 2010